JLL Partners stands to make 4x to 5x its investment in Patheon NV, according to a source with knowledge of the deal. Thermo Fisher Scientific is expected to close its acquisition of the drug-manufacturing business in the next three to five ...DON'T MISS IT! Now in its 10th year, PartnerConnect Midwest is bringing you 300 attendees, over 400 private ExecConnect meetings between LPs and GPs, and three insightful tracks including Buyouts Funds, Buyouts Deals and Co-Investments. REGISTER TODAY!
This content is available for Buyouts subscribers only. Request a free trial to get access for a limited period